Results 331 to 340 of about 1,006,148 (403)

The Evolution of Pneumocystis jirovecii Pneumonia Prophylaxis for Pediatric Patients With Extracranial Solid Tumors: A Review of Historical Insights and Future Directions

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pneumocystis jirovecii pneumonia (PJP) remains a modern‐day complication for pediatric patients receiving treatment for extracranial solid tumors (ST), highlighting the need for reconsideration of our current approach toward PJP prophylaxis. This critical review aims to evaluate both universal and risk‐stratified approaches to PJP prophylaxis ...
Kriti Kumar, Denise M. Connolly, Ellen Kellington, Elyse Zelunka, Karla Kerrigan, Furqan Shaikh, Paul C. Nathan, Meredith S. Irwin, Sarah Cohen‐Gogo   +8 more
wiley   +1 more source

Nigericin‐Triggered Phosphodynamics in Inflammasome Formation and Pyroptosis

PROTEOMICS, EarlyView.
ABSTRACT Innate immune signaling relies heavily on phosphorylation cascades to mount effective immune responses. Although traditional innate immune signaling cascades following TLR4 stimulation have been investigated through a temporally quantitative phosphoproteomic lens, far fewer studies have applied these methods to distinct signaling following the
Vanya Bhushan, Clinton J. Bradfield, Sandhini Saha, Sung Hwan Yoon, Iain D. C. Fraser, Aleksandra Nita‐Lazar   +5 more
wiley   +1 more source

Epigenetic silencing of transposable elements by IRF2BP2 is a selective dependency of myeloid leukemia

Xu J, Whittle J, Clayfield L, Lie-a-ling M, Leddy EA, Smith D, Sellers R, Deniz O, Lacaud G.   +8 more
europepmc   +1 more source

GAB2 couples genetic drivers and signaling networks in acute myeloid leukemia. [PDF]

J Clin Invest
Luvisotto A, Wang L.
europepmc   +1 more source

Targeted and epigenetic therapies for acute myeloid leukemia treatment. [PDF]

Discov Oncol
Shokoohi M, Ghaderi M, Mokarami M, Arian H, Mohammadnabi S, Farokhi A.   +5 more
europepmc   +1 more source

Therapeutic potential of metformin-based combination therapy in acute myeloid leukemia. [PDF]

Discov Oncol
Shamahmood MN, Miri A, Yousefi MJ, Mezginejad F.   +3 more
europepmc   +1 more source

Correction to "Aggressive Disease and Poor Clinical Outcome in CEBPα-Mutated Acute Myeloid Leukemia Patient". [PDF]

Clin Case Rep
europepmc   +1 more source

DHX9 as a prognostic biomarker and its biological roles in acute myeloid leukemia. [PDF]

BMC Cancer
Xiong Y, Chen Y, Luo H, Shi M, Wang C, Hu X, Zhu H.   +6 more
europepmc   +1 more source

Lactylation modification regulates acute myeloid leukemia pathogenesis and immune microenvironment. [PDF]

Discov Oncol
Dai R, Sui G.
europepmc   +1 more source